EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieÄquivalenzstudieOpen Access · CC BY-NC-ND 4.0

Impact of C-reactive protein point-of-care testing on antibiotic prescriptions for children and adults with suspected respiratory tract infections in primary care: a French patient-level randomized controlled superiority trial

Camille Jung, Corinne Levy, Stéphane Béchet, Philippe Aegerter, Robert Cohen, Robert Touitou, VIP Study Investigators

Clinical Microbiology and Infection · 2024-12 · 30 (12) · 1553-1558

DOI: 10.1016/j.cmi.2024.07.014 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Microbiology and Infection, 2024-12. Verfasst von Camille Jung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Centre, Centre Hospitalier Intercommunal (CHI) Creteil, Creteil, France; Institut Mondor de Recherche Biomédicale-Groupement de Rec…. Hauptthemen laut MEDLINE: C-Reactive Protein, Anti-Bacterial Agents, Respiratory Tract Infections, Point-of-Care Testing. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The value of C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescriptions in adults has previously been emphasized. The aim of this study was to assess the impact of CRP POCT on antibiotic prescriptions by general practitioners (GPs) for suspected lower respiratory tract infections in children ≥3 years old and in adults. METHODS: This was an open-label randomized trial (NCT03540706) conducted in 26 GPs in France between October 2019 and March 2023. Of the 404 participating patients, 207 (51.2%) were randomized to the CRP POCT group and 197 (48.8%) to the control group (i.e. no CRP POCT). During consultations, GPs measured CRP levels in patients randomized to the CRP POCT group. The primary endpoint was the proportion of patients in each group who were prescribed antibiotics by their GP during the consultation. Z-tests were used for comparisons. RESULTS: The overall proportion of patients treated with antibiotics was similar in the CRP POCT (n = 89/207, 43% CI: 36.2, 50.0) and in the control group (n = 94/197, 47.7% CI: 40.6, 54.9), difference: -4.7 CI: -14.4, 5.0; p 0.3. Overall, 75% of the GPs followed CRP-based antibiotic prescription recommendations in the CRP POCT group. DISCUSSION: CRP POCT did not reduce antibiotic prescriptions in this trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

C-Reactive ProteinAnti-Bacterial AgentsRespiratory Tract InfectionsPoint-of-Care TestingPrimary Health CareHumansMaleFranceFemaleAdultChild, PreschoolMiddle AgedDrug PrescriptionsChildGeneral PractitionersAdolescentAgedPractice Patterns, Physicians'Young Adult

Stichwörter der Autor:innen

CRP point-of-care testingChildrenElderlyLower respiratory tract infectionsPrimary care

Substanzen

C-Reactive ProteinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Clinical Research Centre, Centre Hospitalier Intercommunal (CHI) Creteil, Creteil, France; Institut Mondor de Recherche Biomédicale-Groupement de Recherche Clinique GEMINI (IMRB-GRC GEMINI), University of Paris Est, Cre…
  • Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV), Créteil, France.
  • Groupement Inter-Régional de Recherche Clinique et d'Innovation, Paris, France.
  • Private Primary Care Department, Paris, France.

Zitieren

APA

Jung, C., Levy, C., Béchet, S., Aegerter, P., Cohen, R., Touitou, R., & VIP Study Investigators (2024). Impact of C-reactive protein point-of-care testing on antibiotic prescriptions for children and adults with suspected respiratory tract infections in primary care: a French patient-level randomized controlled superiority trial. Clinical Microbiology and Infection, 30(12), 1553-1558. https://doi.org/10.1016/j.cmi.2024.07.014

Vancouver

Jung C, Levy C, Béchet S, Aegerter P, Cohen R, Touitou R, et al. Impact of C-reactive protein point-of-care testing on antibiotic prescriptions for children and adults with suspected respiratory tract infections in primary care: a French patient-level randomized controlled superiority trial. Clinical Microbiology and Infection. 2024;30(12):1553-1558. doi:10.1016/j.cmi.2024.07.014

BibTeX
@article{Jung2024,
  author = {Jung, Camille and Levy, Corinne and Béchet, Stéphane and Aegerter, Philippe and Cohen, Robert and Touitou, Robert and VIP Study Investigators, VIP Study Investigators},
  title = {Impact of C-reactive protein point-of-care testing on antibiotic prescriptions for children and adults with suspected respiratory tract infections in primary care: a French patient-level randomized controlled superiority trial},
  journal = {Clinical Microbiology and Infection},
  year = {2024},
  volume = {30},
  number = {12},
  pages = {1553--1558},
  doi = {10.1016/j.cmi.2024.07.014}
}
Kostenlos starten →